Jennifer Guckert Griffin - 04 Nov 2024 Form 3 Insider Report for AMEDISYS INC (AMED)

Role
Chief Legal Officer
Signature
Jennifer Guckert Griffin
Issuer symbol
AMED
Transactions as of
04 Nov 2024
Net transactions value
$0
Form type
3
Filing time
13 Nov 2024, 17:07:03 UTC
Next filing
31 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMED Common Stock 17,507 04 Nov 2024 Direct F1
holding AMED Common Stock 341 04 Nov 2024 By 401(k) Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMED Stock Option (Right to Buy) 04 Nov 2024 Common Stock 496 $264.00 Direct F3
holding AMED Stock Option (Right to Buy) 04 Nov 2024 Common Stock 563 $214.74 Direct F4
holding AMED Stock Option (Right to Buy) 04 Nov 2024 Common Stock 640 $132.41 Direct F5
holding AMED Stock Option (Right to Buy) 04 Nov 2024 Common Stock 327 $95.76 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 551 time-based restricted stock units ("RSUs") that vest on February 16, 2025; 552 time-based RSUs that vest on each of February 16, 2026, 2027 and 2028; 3,655 time-based RSUs that vest on June 26, 2025; 3,654 time-based RSUs that vest on June 26, 2026; 647 time-based RSUs that vest on each of May 3, 2025 and 2026; 648 time-based RSUs that vest on May 3, 2027; 349 time-based RSUs that vest on each of June 1, 2025 and 2026; and 50 time-based RSUs that vest on July 25, 2025, assuming in each case that the Reporting Person remains continuously employed by the Issuer on each such vesting date. Also includes 294 shares held in an employee stock purchase plan account.
F2 The information in this report is based on a plan statement dated as of September 30, 2024.
F3 The stock options are subject to time-based vesting conditions. 372 stock options are fully vested and immediately exercisable, and 124 stock options will vest on July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on such date.
F4 All 563 stock options are fully vested and immediately exercisable.
F5 All 640 stock options are fully vested and immediately exercisable.
F6 All 327 stock options are fully vested and immediately exercisable.

Remarks:

Exhibit 24.1 - Power of Attorney